Department-Wide Task Force Sets Nov. 8 Agenda For Med Tech Innovation
This article was originally published in The Gray Sheet
Executive Summary
HHS' task force on stimulating innovation in medical technologies will convene in Washington, D.C. Nov. 8 to review 12-15 "promising ideas" gleaned from stakeholder comments this summer
You may also be interested in...
Critical Path Still Critical, But Delayed By Drug Safety Agenda – FDA
Greater investments in tracking drug safety issues could continue to slow the implementation timeline for FDA's Critical Path initiative
Critical Path Still Critical, But Delayed By Drug Safety Agenda – FDA
Greater investments in tracking drug safety issues could continue to slow the implementation timeline for FDA's Critical Path initiative
Cross-Agency Forum, Trial Standardization Pushed By HHS Innovation Report
CDRH and NIH will establish a forum within the next six months to improve inter-agency cooperation and act as a sounding board for investigators and manufacturers